An Observational Study of Patients With Autoimmune Disease

Target PharmaSolutions

Status: Not yet enrolling

Conditions: Autoimmune Diseases

Study type: Observational

Funder types: Industry

Identifiers

NCT05842824

TARGET-AUTOIMMUNE

Details and patient eligibility

About

TARGET-AUTOIMMUNE is an observational research study to conduct a comprehensive review of outcomes for patients with autoimmune and related diseases. .

Enrollment: 500,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Disease Cohort

Inclusion Criteria:

• Adult patients at the time of enrollment with a diagnosis autoimmune disease by select ICD-10 codes in the EHR interface

Exclusion Criteria:

• Death
• Manual removal (sponsor or site request)
• No EHR interface encounter > 3 years

Engaged Cohort

Inclusion Criteria:

• Adult patients diagnosed and managed for these conditions invited to participate
• Ability to provide written informed consent

Exclusion Criteria:

• Patient expressed desire to withdraw consent to complete PROs
• Failure to complete PROs within 24 weeks of initial invitation
• Greater than 24 months lapse of survey completion after baseline surveys completed
• Additionally, the criteria detailed for Disease Cohort apply to the Engaged Cohort

Trial design

500,000 participants in 2 patient groups

Disease Cohort

Description:

Observational

Engaged Cohort

Description:

Observational